Dyadic to present at roth investor conference and upcoming industry events

Jupiter, fla., march 01, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that its management and business partners from vtt technical research centre of finland ltd, will be participating at the following investor and industry events.
DYAI Ratings Summary
DYAI Quant Ranking